Cargando…
A non-homogeneous Markov early epidemic growth dynamics model. Application to the SARS-CoV-2 pandemic
This work introduces a new markovian stochastic model that can be described as a non-homogeneous Pure Birth process. We propose a functional form of birth rate that depends on the number of individuals in the population and on the elapsed time, allowing us to model a contagion effect. Thus, we model...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500902/ https://www.ncbi.nlm.nih.gov/pubmed/32982083 http://dx.doi.org/10.1016/j.chaos.2020.110297 |
_version_ | 1783583945709846528 |
---|---|
author | Barraza, Néstor Ruben Pena, Gabriel Moreno, Verónica |
author_facet | Barraza, Néstor Ruben Pena, Gabriel Moreno, Verónica |
author_sort | Barraza, Néstor Ruben |
collection | PubMed |
description | This work introduces a new markovian stochastic model that can be described as a non-homogeneous Pure Birth process. We propose a functional form of birth rate that depends on the number of individuals in the population and on the elapsed time, allowing us to model a contagion effect. Thus, we model the early stages of an epidemic. The number of individuals then becomes the infectious cases and the birth rate becomes the incidence rate. We obtain this way a process that depends on two competitive phenomena, infection and immunization. Variations in those rates allow us to monitor how effective the actions taken by government and health organizations are. From our model, three useful indicators for the epidemic evolution over time are obtained: the immunization rate, the infection/immunization ratio and the mean time between infections (MTBI). The proposed model allows either positive or negative concavities for the mean value curve, provided the infection/immunization ratio is either greater or less than one. We apply this model to the present SARS-CoV-2 pandemic still in its early growth stage in Latin American countries. As it is shown, the model accomplishes a good fit for the real number of both positive cases and deaths. We analyze the evolution of the three indicators for several countries and perform a comparative study between them. Important conclusions are obtained from this analysis. |
format | Online Article Text |
id | pubmed-7500902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75009022020-09-21 A non-homogeneous Markov early epidemic growth dynamics model. Application to the SARS-CoV-2 pandemic Barraza, Néstor Ruben Pena, Gabriel Moreno, Verónica Chaos Solitons Fractals Article This work introduces a new markovian stochastic model that can be described as a non-homogeneous Pure Birth process. We propose a functional form of birth rate that depends on the number of individuals in the population and on the elapsed time, allowing us to model a contagion effect. Thus, we model the early stages of an epidemic. The number of individuals then becomes the infectious cases and the birth rate becomes the incidence rate. We obtain this way a process that depends on two competitive phenomena, infection and immunization. Variations in those rates allow us to monitor how effective the actions taken by government and health organizations are. From our model, three useful indicators for the epidemic evolution over time are obtained: the immunization rate, the infection/immunization ratio and the mean time between infections (MTBI). The proposed model allows either positive or negative concavities for the mean value curve, provided the infection/immunization ratio is either greater or less than one. We apply this model to the present SARS-CoV-2 pandemic still in its early growth stage in Latin American countries. As it is shown, the model accomplishes a good fit for the real number of both positive cases and deaths. We analyze the evolution of the three indicators for several countries and perform a comparative study between them. Important conclusions are obtained from this analysis. Elsevier Ltd. 2020-10 2020-09-18 /pmc/articles/PMC7500902/ /pubmed/32982083 http://dx.doi.org/10.1016/j.chaos.2020.110297 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Barraza, Néstor Ruben Pena, Gabriel Moreno, Verónica A non-homogeneous Markov early epidemic growth dynamics model. Application to the SARS-CoV-2 pandemic |
title | A non-homogeneous Markov early epidemic growth dynamics model. Application to the SARS-CoV-2 pandemic |
title_full | A non-homogeneous Markov early epidemic growth dynamics model. Application to the SARS-CoV-2 pandemic |
title_fullStr | A non-homogeneous Markov early epidemic growth dynamics model. Application to the SARS-CoV-2 pandemic |
title_full_unstemmed | A non-homogeneous Markov early epidemic growth dynamics model. Application to the SARS-CoV-2 pandemic |
title_short | A non-homogeneous Markov early epidemic growth dynamics model. Application to the SARS-CoV-2 pandemic |
title_sort | non-homogeneous markov early epidemic growth dynamics model. application to the sars-cov-2 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500902/ https://www.ncbi.nlm.nih.gov/pubmed/32982083 http://dx.doi.org/10.1016/j.chaos.2020.110297 |
work_keys_str_mv | AT barrazanestorruben anonhomogeneousmarkovearlyepidemicgrowthdynamicsmodelapplicationtothesarscov2pandemic AT penagabriel anonhomogeneousmarkovearlyepidemicgrowthdynamicsmodelapplicationtothesarscov2pandemic AT morenoveronica anonhomogeneousmarkovearlyepidemicgrowthdynamicsmodelapplicationtothesarscov2pandemic AT barrazanestorruben nonhomogeneousmarkovearlyepidemicgrowthdynamicsmodelapplicationtothesarscov2pandemic AT penagabriel nonhomogeneousmarkovearlyepidemicgrowthdynamicsmodelapplicationtothesarscov2pandemic AT morenoveronica nonhomogeneousmarkovearlyepidemicgrowthdynamicsmodelapplicationtothesarscov2pandemic |